IRCT2015042221886N2CompletedPhase 2
Evaluation of the effect of tamsulosin on relief of ureteral stent discomfort in patients with urolithiasis
Exir Pharmaceutical Company0 sites70 target enrollmentStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- Phase 2
- Status
- Completed
- Sponsor
- Enrollment
- 70
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 years to no limit (—)
- Sex
- All
Inclusion Criteria
- •age equal to 18 and more; urolithiasis indicated for transurethral litotripsy and Double J ureteral stenting thereafter.
- •Exclusion criteria: significant ureteral trauma; presence of previous ureteral stent; other concurrent operations; previous prostate resection; bladder tumors; urinary infections; history of chronic pain; pregnancy; age less than 18; prostate cancer; cardiovascular disease, coronary artery disease.
Exclusion Criteria
- Not provided
Investigators
Similar Trials
Recruiting
Phase 2
Tamsulosin for treatment of urinary tract disorder in womeIRCT20200111046086N1Tabriz University of Medical Sciences252
Completed
Not Applicable
Effect of tamsulosin on nightmaresIRCT201412163106N21Islamic azad university of pharmaceutical sciense20
Completed
Phase 3
The effect of Tamsulosin and Solifenacin in the treatment of double J stent-related urinary symptomsIRCT20200831048564N1Mashhad University of Medical Sciences80
Recruiting
Phase 4
Comparative efficacy assessment of Tamsulosin vs. Tamsulosin plus Pentoxifylline in the treatment of LUTS/BPH: A preliminary studyIRCT20210729052012N1Shiraz University of Medical Sciences60
Completed
Not Applicable
Efficacy of Tamsulosin in relieving urinary symptoms due to JJ stentCTRI/2014/08/004824niversity College of Medical Sciences University of Delhi and GTB Hospital60